Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course-Reference-Cited by-同舟云学术

Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course

Published:2014-05 Issue:5 Volume:43 Page:470-473
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Carlier Mieke,Carrette Sofie,Stove Veronique,Verstraete Alain G.,De Waele Jan J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012;Dellinger;Intens Care Med,2013

2. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock;Taccone;Crit Care,2010

3. Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations;Udy;Chest,2012

4. Pharmacokinetic issues for antibiotics in the critically ill patient;Roberts;Crit Care Med,2009

5. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?;Carlier;Crit Care,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review;Antibiotics;2024-08-24

2. Utilizing Ceftazidime/Avibactam Therapeutic Drug Monitoring in the Treatment of Neurosurgical Meningitis Caused by Difficult-to-Treat Resistant Pseudomonas aeruginosa and KPC-Producing Enterobacterales;Open Forum Infectious Diseases;2023-10-19

3. The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example;Antibiotics;2023-09-13

4. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study;Therapeutic Drug Monitoring;2023-03-21

5. Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review;Therapeutic Drug Monitoring;2022-12